CXCR2 and Miyoshi myopathy: We postulate that CXCL7 activates the JAK/STAT3 pathway via CXCR2, thereby influencing the proliferation of MM cells and further triggering the expression of downstream activating proteins associated with the osteoclast signaling pathway (Fig. 6D).